VivoSim Labs (VIVS) Retained Earnings (2011 - 2026)
VivoSim Labs (VIVS) posted Retained Earnings of -$357.3 million for Q2 2026, little changed on a QoQ basis from -$356.0 million in Q1 2026, and down 3.58% year-over-year from -$370.6 million in Q2 2025.
Analysis
VivoSim Labs (VIVS) Retained Earnings (2011 - 2026) Analysis & Trends
VivoSim Labs has reported Retained Earnings for 16 years, with the latest figure at -$357.3 million in Q2 2026.
- On a quarterly basis, Retained Earnings fell 3.58% year-over-year to -$357.3 million in Q2 2026; TTM through Jun 2026 was -$357.3 million, a 3.58% decrease from a year earlier, with the FY2026 full-year figure at -$356.0 million, down 4.05% from the prior year.
- Retained Earnings was -$357.3 million for Q2 2026 at VivoSim Labs, roughly flat from -$356.0 million in the prior quarter.
- The five-year high for Retained Earnings was -$307.7 million in Q1 2022, with the low at -$357.3 million in Q2 2026.
- Average Retained Earnings over 5 years is -$336.1 million, with a median of -$340.9 million recorded in 2024.
- The sharpest annual moves came in 2023 and 2025: Retained Earnings retreated 6.01% in 2023, then decreased 0.35% in 2025.
- Over 5 years, Retained Earnings stood at -$317.5 million in 2022, then declined by 6.01% to -$336.6 million in 2023, then retreated by 3.68% to -$349.0 million in 2024, then declined by 0.35% to -$350.2 million in 2025, then declined by 2.03% to -$357.3 million in 2026.
- The last three Retained Earnings figures came in at -$357.3 million (Q2 2026), -$356.0 million (Q1 2026), and -$350.2 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 7.96 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | -511.37 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 2.30 Bn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 1.37 Bn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 2.14 Bn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 1.71 Bn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 6.70 Bn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -81.50 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -106.74 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -357.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -357.34 Mn |
| Mar 31, 2026 | -356.00 Mn |
| Dec 31, 2025 | -350.24 Mn |
| Sep 30, 2025 | -347.55 Mn |
| Jun 30, 2025 | -345.00 Mn |
| Mar 31, 2025 | -342.16 Mn |
| Dec 31, 2024 | -349.01 Mn |
| Sep 30, 2024 | -345.60 Mn |
| Jun 30, 2024 | -343.01 Mn |
| Mar 31, 2024 | -339.67 Mn |
| Dec 31, 2023 | -336.62 Mn |
| Sep 30, 2023 | -333.02 Mn |
| Jun 30, 2023 | -329.03 Mn |
| Mar 31, 2023 | -325.00 Mn |
| Dec 31, 2022 | -317.54 Mn |
| Sep 30, 2022 | -314.30 Mn |
| Jun 30, 2022 | -311.00 Mn |
| Mar 31, 2022 | -307.74 Mn |
| Dec 31, 2021 | -305.83 Mn |
| Sep 30, 2021 | -302.33 Mn |